These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4229554)

  • 1. [Homovanillic acid in the cerebrospinal fluid: studies in Parkinson's syndrome and other diseases of the CNS].
    Bernheimer H; Birkmayer W; Hornykiewicz O
    Wien Klin Wochenschr; 1966 Jun; 78(23):417-9. PubMed ID: 4229554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
    Lipman IJ; Papadopoulos NM
    Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
    Voto Bernales J; Cruz GA; Davila E
    Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
    [No Abstract]   [Full Text] [Related]  

  • 5. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 6. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
    Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
    [No Abstract]   [Full Text] [Related]  

  • 7. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA; Roos BE
    Confin Neurol; 1972; 34(2):136-42. PubMed ID: 4579783
    [No Abstract]   [Full Text] [Related]  

  • 8. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
    West KA; Roos BE
    Confin Neurol; 1972; 34(1):136-42. PubMed ID: 4538913
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation between Parkinsonism symptoms and a disorder in the amino acid metabolism in CNS].
    Gründig E; Gerstenbrand F
    Wien Klin Wochenschr; 1970 Nov; 82(45):811-6. PubMed ID: 5479021
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Hydroxyindoleacetic acid in cerebrospinal fluid.
    Molnár G; Fodor A; Karczag I; Szilágyi A; Ujvárosi I
    Acta Med Acad Sci Hung; 1973; 30(3):211-7. PubMed ID: 4785998
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
    Johannsson B; Roos BE
    Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
    [No Abstract]   [Full Text] [Related]  

  • 13. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid.
    Christensen SE; Dupont E; Mondrup K; Olivarius BF; Orskov H
    Adv Neurol; 1984; 40():325-31. PubMed ID: 6229980
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of spinal fluid homovanillic acid (HVA) in patients with diseases of the nervous system.
    Mones RJ; Wilk S; Green J; Jutkowitz R
    Mt Sinai J Med; 1972; 39(5):478-85. PubMed ID: 4538762
    [No Abstract]   [Full Text] [Related]  

  • 16. Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5HIAA) during L-dopa therapy of Parkinson's disease.
    van Woert MH; Bowers MB
    Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534981
    [No Abstract]   [Full Text] [Related]  

  • 17. On the occurrence of homovanillic acid and 5-hydroxyindol-3-ylacetic acid in the ventricular C.S.F. of patients suffering from parkinsonism.
    Guldberg HC; Turner JW; Hanieh A; Ashcroft GW; Crawford TB; Perry WL; Gillingham FJ
    Confin Neurol; 1967; 29(2):73-7. PubMed ID: 5588903
    [No Abstract]   [Full Text] [Related]  

  • 18. [Homovanillic acid concentration of the cerebrospinal fluid in epilepsy].
    Kobayashi K; Ebara Y; Hosokawa K; Oku Y
    No To Shinkei; 1976 Apr; 28(4):371-7. PubMed ID: 829031
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
    Chase TN
    Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal homovanillic acid and parkinsonism.
    Miachon S; Dalmaz Y; Cottet-Emard JM; Peyrin L
    Biomedicine; 1974 Jul; 21(7):303-8. PubMed ID: 4433665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.